Oral solid dose vaccine

Details for Australian Patent Application No. 2001286168 (hide)

Owner GlaxoSmithKline Biologicals S.A.

Inventors Vande-Velde, Vincent

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2001286168

PCT Pub. Number WO02/13858

Priority 0020089.91 15.08.00 GB

Filing date 14 August 2001

Wipo publication date 25 February 2002

Acceptance publication date 23 September 2004

International Classifications

A61K 039/39 Medicinal preparations containing antigens or antibodies - characterised by the immunostimulating additives, e.g. chemical adjuvants

A61K 039/12 Medicinal preparations containing antigens or antibodies - Viral antigens

A61K 039/02 Medicinal preparations containing antigens or antibodies - Bacterial antigens

A61K 009/20 Medicinal preparations characterised by special physical form - Pills, lozenges or tablets

A61K 039/00 Medicinal preparations containing antigens or antibodies

Event Publications

23 September 2004 Application Accepted

  Published as AU-B-2001286168

20 January 2005 Standard Patent Sealed

24 April 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2001286169-Method for reducing the sox emission from a plant for manufacturing cement clinker and such plant

2001286167